Nosocomial transmission of Candida pelliculosa fungemia in a pediatric intensive care unit and review of the literature

Turkish Journal of Pediatrics

Volumn 52, Issue 1, 2010, Pages 42-49

  Kalkanci, Ayşe ^a   Dizbay, Murat ^a   Turan, Özden ^a   Fidan, Işil ^a   Yalçin, Burçe ^a   Hirfanoǧlu, Ibrahim ^a   Kuştimur, Semra ^a   Aktaş, Firdevs ^a   Sugita, Takashi ^b  

^a GAZI UNIVERSITY   (Turkey)

^b MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Candida pelliculosa; Fungemia; Nosocomial; Pediatric intensive care unit; Pichia anomala

Indexed keywords

AMIKACIN; AMPHOTERICIN B; AMPICILLIN; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; MEROPENEM; MICAFUNGIN; MICONAZOLE; TEICOPLANIN; VORICONAZOLE;

ANTIBIOTIC PROPHYLAXIS; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; ARTIFICIAL VENTILATION; CANDIDA; CANDIDEMIA; CASE REPORT; CATHETER REMOVAL; CENTRAL VENOUS CATHETER; CHILD HOSPITALIZATION; DISEASE TRANSMISSION; DNA FINGERPRINTING; DNA SEQUENCE; FUNGUS ISOLATION; HOSPITAL INFECTION; HOSPITAL PERSONNEL; HUMAN; INFANT; INFECTION CONTROL; INFECTION RISK; INTENSIVE CARE UNIT; PICHIA ANOMALA; RANDOM AMPLIFIED POLYMORPHIC DNA; RISK FACTOR; TERTIARY HEALTH CARE; TOTAL PARENTERAL NUTRITION; TURKEY (REPUBLIC);

CANDIDA; CANDIDIASIS; CLUSTER ANALYSIS; CROSS INFECTION; FUNGEMIA; HUMANS; INFANT, NEWBORN; INFECTION CONTROL; INTENSIVE CARE UNITS, PEDIATRIC; JAPAN; MICROBIAL SENSITIVITY TESTS; SEQUENCE ANALYSIS, DNA;

EID: 77950381999     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Zaoutis TE, Heydon K, Localio R, Walsh TJ, Feudtner C. Outcomes attributable to neonatal candidiasis. Clin Infect Dis 2007; 44: 1187-1193.
2. Zaoutis TE, Argon J, Chu J, Berlin JA, Walsh TJ, Feudtner C. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin Infect Dis 2005; 41: 1232-1239.
3. Pappas PG, Rex JH, Lee J, et al. A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis 2003; 37: 634-643.
4. Lopes JM, Goulart EM, Starling CE. Pediatric mortality due to nosocomial infection: a critical approach. Braz J Infect Dis 2007; 11: 515-519.
5. Lupetti A, Tavanti A, Davini P, et al. Horizontal transmission of Candida parapsilosis candidemia in a neonatal intensive care unit. J Clin Microbiol 2002; 40: 2363-2369.
6. Roilides E, Farmaki E, Evdoridou J, et al. Candida tropicalis in a neonatal intensive care unit: epidemiologic and molecular analysis of an outbreak of infection with an uncommon neonatal pathogen. J Clin Microbiol 2003; 41: 735-741.
7. Chakrabarti A, Singh K, Narang A, et al. Outbreak of Pichia anomala infection in the pediatric service of a tertiary-care center in Northern India. J Clin Microbiol 2001; 39: 1702-1706.
8. Belet N, Ciftçi E, Ince E, et al. Caspofungin treatment in two infants with persistent fungaemia due to Candida lipolytica. Scand J Infect Dis 2006; 38: 559-562.
9. de Hoog GS, Guarro J, Gene J, Figueras MJ. Atlas of Clinical Fungi (2nd ed). Holland: CBS; 2000: 215-216.
10. Aragão PA, Oshiro IC, Manrique EI, et al. Pichia anomala outbreak in a nursery: exogenous source? Pediatr Infect Dis J 2001; 20: 843-848.
11. Thuler LC, Faivichenco S, Velasco E, Martins CA, Nascimento CR, Castilho IA. Fungaemia caused by Hansenula anomala - an outbreak in a cancer hospital. Mycoses 1997; 40: 193-196.
12. Bakir M, Cerikcioglu N, Tirtir A, Berrak S, Ozek E, Canpolat C. Pichia anomala fungemia in immunocompromised children. Mycoses 2004; 47: 231-235.
13. Pasqualotto AC, Sukiennik TC, Severo LC, de Amorim CS, Colombo AL. An outbreak of Pichia anomala fungemia in a Brazilian pediatric intensive care unit. Infect Control Hosp Epidemiol 2005; 26: 553-558.
14. Paula CR, Krebs VL, Auler ME, et al. Nosocomial infection in newborns by Pichia anomala in a Brazilian intensive care unit. Med Mycol 2006; 44: 479-484.
15. Singh K, Chakrabarti A, Narang A, Gopalan S. Yeast colonisation & fungaemia in preterm neonatas in a tertiary care centre. Indian J Med Res 1999; 110: 169-173.
16. Levin AS, Costa SF, Mussi NS, et al. Candida parapsilosis fungemia associated with implantable and semi-implantable central venous catheters and hands of health care workers. Diagn Microbiol Infect Dis 1998; 30: 243-249.
17. Sugita T, Tajima M, Tsubuku H, Tsuboi R, Nishikawa A. Quantitative analysis of cutaneous Malessezia in atopic dermatitis patients using real-time PCR. Microbiol Immunol 2006; 50: 549-552.
18. Bakir M, Cerikcioglu N, Barton R, Yagci A. Epidemiology of candidemia in a Turkish tertiary care hospital. APMIS 2006; 111: 601-610.
19. Huang YC, Lin TY, Leu HS, Wu JL, Wu JH. Yeast carriage on hands of hospital personnel working in intensive care units. J Hosp Infect 1998; 39: 47-51.
20. Reef SE, Lasker BA, Butcher DS, et al. Nonperinatal nosocomial transmission of Candida albicans in a neonatal intensive care unit: prospective study. J Clin Microbiol 1998; 36: 1255-1259.
21. Welbel SF, McNeil MM, Kuykendall RJ, et al. Candida parapsilosis bloodstream infections in neonatal intensive care unit patients: epidemiologic and laboratory confirmation of a common source outbreak. Pediatr Infect Dis J 1996; 15: 998-1002.
22. Faix RG, Finkel DJ, Andersen RD, Hostetter MK. Genotypic analysis of a cluster of systemic Candida albicans infections in a neonatal intensive care unit. Pediatr Infect Dis J 1995; 14: 1063-1068.
23. de Montemayor L, Gamboa A. Description of a new strain of "Candida pelliculosa, Redaelli 1925", isolated from clinical material of human origin. Gac Med Caracas 1959; 67: 327-337 (Spanish).
24. Wang CJ, Schwarz J. The etiology of interstitial pneumonia identification as Hansenula anomala of a yeast isolated from lungs of infants. Mycopathol Mycol Appl 1958; 9: 299-306.
25. Makhoul IR, Kassis I, Smolkin T, Tamir A, Sujov P. Review of 49 neonates with acquired fungal sepsis: further characterization. Pediatrics 2001; 107: 61-66.
26. Barchiesi F, Tortorano AM, Di Francesco AF, et al. Genotypic variation and antifungal susceptibilities of Candida pelliculosa clinical isolates. J Medical Microbiol 2005; 54: 279-285.
27. Ergon MC, Yucesoy M. Molecular epidemiology of Candida species isolated from urine at an intensive care unit. Mycoses 2005; 48: 126-131.
28. Humhreys H. Does molecular typing make any contribution to the care of patients with infection? Clin Microbiol Infect 2004; 10: 269-271.
29. Mestroni SC, Bava AL. Hansenula anomala fungemia. Rev Argent Microbiol 2003; 35: 54-56.
30. Kane SL, Dasta JF, Cook CH. Amphotericin B lipid complex for Hansenula anomala pneumonia. Ann Pharmacother 2002; 36: 59-62.
31. Hanzen J, Krcmery V. Polyfungal candidaemia due to Candida rugosa and Candida pelliculosa in a haemodialyzed neonate. Scand J Infect Dis 2002; 34: 555.
32. Kalenic S, Jandrlic M, Vegar V, Zuech N, Sekulic A, Mlinaric-Missoni E. Hansenula anomala outbreak at a surgical intensive care unit: a search for risk factors. Eur J Epidemiol 2001; 17: 491-496.
33. Ma JS, Chen PY, Chen CH, Chi CS. Neonatal fungemia caused by Hansenula anomala: a case report. J Microbiol Immunol Infect 2000; 33: 267-270.
34. Wong Ar, Ibrahim H, van Rostenberghe H, Ishak Z, Radzi MJ. Hansenula anomala infection in a neonate. J Pediatric Child Health 2000; 36: 609-610.
35. Kunova A, Spanik S, Kollar T, Krcmery V Jr. Breakthrough fungemia due to Hansenula anomala in a leukemia patient successfully treated with amphotericin B. J Chemother 1996; 8: 85-86.
36. Sumitomo M, Kawata K, Kaminaga Y, Ito A, Makimura K, Yamaguchi H. Hansenula anomala fungemia in a patient undergoing IVH-treatment with ascending colon carcinoma. Kansenshogaku Zasshi 1996; 70: 198-205.
37. Yamada S, Maruoka T, Nagai K, et al. Catheter-related infections by Hansenula anomala in children. Scand J Infect Dis 1995; 27: 85-87.
38. Goss G, Grigg A, Rathbone P, Slavin M. Hansenula anomala infection after bone marrow transplantation. Bone Marrow Transplant 1994; 14: 995-997.
39. Alter SJ, Farley J. Development of Hansenula anomala infection in a child receiving fluconazole therapy. Pediatr Infect Dis J 1994; 13: 158-159.
40. Hirasaki S, Ijichi T, Fujita N, Araki S, Gotoh H, Nakagawa M. Fungemia caused by Hansenula anomala: successful treatment with fluconazole. Intern Med 1992; 31: 622-624.
41. Sekhon AS, Kowalewska-Grochowska K, Garg AK, Vaudry W. Hansenula anomala fungemia in an infant with gastric and cardiac complications with a review of the literature. Eur J Epidemiol 1992; 8: 305-308.
42. Neumeister B, Rockemann M, Marre R. Fungemia due to Candida pelliculosa in a case of acute pancreatitis. Mycoses 1992; 35: 309-310.
43. Salesa R, Burgos A, Fernandez-Mazarrasa C, Quindos G, Ponton J. Transient fungaemia due to Candida pelliculosa in a patient with AIDS. Mycoses 1991; 34: 327-329.
44. López F, Martín G, Paz ML, Sanz MA. Hansenula anomala infection in acute leukemia. Enferm Infecc Microbiol Clin 1990; 8: 363-364 (Spanish).
45. Dickensheets DL. Hansenula anomala infection. Rev Infect Dis 1989; 11: 507-508.
46. Muñoz P, Garcia Leoni ME, Berenguer J, Bernaldo de Quiros JC, Bouza E. Catheter-related fungemia by Hansenula anomala. Arch Intern Med 1989; 149: 709-713.
47. Qadri SM, Al Dayel F, Strampfer MJ, Cunha BA. Urinary tract infection caused by Hansenula anomala. Mycopathologia 1988; 104: 99-101.
48. Haron E, Anaissie E, Dumphy F, McCredie K, Fainstein V. Hansenula anomala fungemia. Rev Infect Dis 1988; 10: 1182-1186.
49. Klein AS, Tortora GT, Malowitz R, Greene WH. Hansenula anomala: a new fungal pathogen. Two case reports and a review of the literature. Arch Intern Med 1988; 148: 1210-1213.
50. Nohinek B, Zee-Cheng CS, Barnes WG, Dall L, Gibbs HR. Infective endocarditis of a bicuspid aortic valve caused by Hansenula anomala. Am J Med 1987; 82: 165-168.
51. Milstoc M, Siddiqui NA. Fungemia due to Hansenula anomala. N Y State J Med 1986; 86: 541-542.
52. Murphy N, Buchanan CR, Damjanovic V, Whitaker R, Hart CA, Cooke RW. Infection and colonisation of neonates by Hansenula anomala. Lancet 1986; 1: 291-293.